The FTSE 100 has hit fresh highs again, despite falls in the US.
Consumer goods giant Unilever is reporting strong overall growth in full-year sales, but lower margins meant underlying operating profits only improved slightly in comparison. Total turnover increased 14.5% to €60.1bn.
Watches of Switzerland revenues jumped 17% in its last quarter, driven by the current trend for buying luxury watches.
Elsewhere, pharma giant AstraZeneca says its fourth-quarter numbers undershot market consensus by around $100mln as it felt the impact of declining sales of its Covid vaccine.
And in small caps, Shield Therapeutics confirmed it expects to reach cash flow break even by the end of next year.